Skip to content

Value of Follicular Flushing. Randomised Controlled Trial

Does Addition of Follicular Flushing to the Initial Aspiration Lead to Higher Numbers of Oocytes Retrieved in Women Undergoing Oocyte Retrieval? A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05473455
Enrollment
105
Registered
2022-07-26
Start date
2022-07-15
Completion date
2022-12-31
Last updated
2023-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Follicular Flushing, Oocyte Retrieval

Brief summary

The purpose of this study is to evaluate whether the addition of follicular flushing to the initial aspiration during oocyte retrieval increases the number of oocytes retrieved in women undergoing ovarian stimulation.

Detailed description

There is an ongoing debate regarding the effectiveness of follicular flushing during oocyte retrieval. Currently published studies and metanalyses suggest that follicular flushing does not improve live birth rate, clinical pregnancy rate or the number of oocytes retrieved. However, currently published studies may be confounded by the types of needle used, aspiration pressures, number of times flushing is repeated, etc. Additionally, follicular flushing should be examined in specific patient populations according to their response to ovarian stimulation. In the current study, each woman will have one ovary (right or left) randomly assigned to be aspirated with or without the addition of follicular flushing. This study design ensures that clinical and demographic characteristics of the couple will not affect the outcomes evaluated. The primary endpoints will be the number of oocytes retrieved per ovary assigned to each group. Secondary outcomes will be the oocyte recovery rate (oocytes retrieved per follicle aspirated) oocyte maturation rate, fertilization rate, and embryo development per ovary assigned to each group. The study population will include three subgroups according to observed ovarian response to ovarian stimulation (poor responders, normal responders, hyper responders). Assuming a minimum clinically significant difference in oocyte yield of 1 oocyte, a sample size of twenty patients per subgroup is required to yield 80% power. Patients aged \<43 years with the presence of at least one follicles \>11mm in each ovary on the day of triggering final oocyte maturation will be eligible for inclusion in the study. 60 patients (20 in each of the aforementioned subgroup) will be recruited and just prior to oocyte retrieval their left and right ovaries will be randomly allocated into flushing or the no-flushing group. In both ovaries all follicles greater than 11mm will be punctured by the same 16G double lumen needle, using the same aspiration pressure. In the flushing group, flushing will be performed up to a maximum of five times or until a cumulus oocyte complex (COC) is retrieved. In the control group all follicles greater than 11mm will be aspirated by the same double lumen needle and no flushing will be performed. All COCs will be grouped according to the ovary they originated from by the embryologists and their development will be recorded until Day 3 following fertilization (Number of MII oocytes, number of fertilized oocytes, number good quality Day 3 embryos).

Interventions

PROCEDUREExperimental: Follicular aspiration with addition of follicular flushing.

Follicular flushing if necessary up to 5 times using a double lumen needle for oocyte recovery

Sponsors

Eugonia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 43 Years
Healthy volunteers
No

Inclusion criteria

* Presence of both ovaries * 18-43 years old * At least one follicle \>11mm present in each ovary on day of triggering final oocyte maturation.

Exclusion criteria

* Ovarian surgery * Monofolicular development

Design outcomes

Primary

MeasureTime frameDescription
Number of oocytes retrievedDuring oocyte collection (usually 10-30 minutes)Number of oocytes retrieved per ovary randomised

Secondary

MeasureTime frameDescription
Fertilization rateDuring fertilisation check (usually 10 minutes)Number of fertilised (2PN) oocytes divided by the number of matured oocytes retrieved per ovary randomised
Oocyte recovery rateDuring oocyte collection (usually 10-30 minutes)Number of oocytes retrieved per follicle aspirated
Oocyte maturation rateDuring oocyte denudation (usually 10-30 minutes)Number of mature (metaphase-II) oocytes divided by the number of oocytes retrieved per ovary randomised
Percentage of good quality embryos on day 2/3During embryo evaluation (usually 10 minutes)Number of good quality embryos divided by the number of fertilized oocytes per ovary randomised

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026